URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Neil Blumberg

Concepts (549)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Blood Transfusion
74
1978
166
14.080
Why?
Platelet Transfusion
28
1987
84
10.080
Why?
ABO Blood-Group System
29
1978
66
7.730
Why?
Blood Platelets
31
1981
271
5.430
Why?
Erythrocyte Transfusion
14
1982
58
3.830
Why?
Blood Group Incompatibility
15
1983
37
3.280
Why?
Blood Grouping and Crossmatching
17
1984
32
3.060
Why?
Isoantibodies
22
1982
58
2.660
Why?
Blood Component Transfusion
7
1992
21
2.390
Why?
Blood Transfusion, Autologous
12
1982
23
2.190
Why?
Inflammation
9
2003
518
2.150
Why?
Postoperative Complications
13
1990
706
2.090
Why?
Humans
158
1974
35000
1.970
Why?
Leukemia
8
1982
152
1.930
Why?
Cardiac Surgical Procedures
4
2002
74
1.930
Why?
Hemorrhage
5
1983
173
1.840
Why?
HLA Antigens
7
1982
91
1.740
Why?
Fever
5
2001
106
1.700
Why?
CD40 Ligand
8
2001
92
1.680
Why?
Leukocyte Reduction Procedures
6
2004
13
1.680
Why?
Leukocytes
9
1992
191
1.660
Why?
Blood Preservation
6
1981
24
1.650
Why?
Acute Lung Injury
3
2010
24
1.630
Why?
Thrombosis
4
2008
196
1.500
Why?
Neoplasm Recurrence, Local
14
1985
272
1.460
Why?
Immunity
5
1989
65
1.420
Why?
Blood Donors
6
1982
27
1.340
Why?
Leukapheresis
4
1978
14
1.290
Why?
Coronary Artery Bypass
8
1983
105
1.280
Why?
Thrombocytopenia
5
1988
71
1.250
Why?
Blood Component Removal
2
2003
11
1.220
Why?
Infection
10
1989
66
1.200
Why?
Erythrocytes
6
1983
341
1.160
Why?
Immune Tolerance
7
1990
145
1.140
Why?
Antibodies
4
1983
207
1.120
Why?
Hematologic Neoplasms
3
2006
34
1.100
Why?
Female
61
1978
19061
1.060
Why?
Male
53
1978
18870
0.990
Why?
Neoplasms
13
1974
701
0.960
Why?
Fibrinogen
4
1988
149
0.950
Why?
Factor VIII
3
1988
50
0.950
Why?
Blood Banks
3
2001
12
0.910
Why?
Histocompatibility Testing
2
2005
37
0.910
Why?
Anemia
3
1998
76
0.900
Why?
Lewis Blood-Group System
7
1983
11
0.890
Why?
Cross Infection
4
1992
85
0.880
Why?
Retrospective Studies
18
1982
2167
0.880
Why?
Length of Stay
3
2002
284
0.870
Why?
Communicable Diseases
2
1997
22
0.870
Why?
Bone Marrow Transplantation
4
1994
189
0.840
Why?
Vascular Diseases
2
2006
68
0.830
Why?
Middle Aged
32
1978
9461
0.830
Why?
Blood Specimen Collection
2
1981
29
0.830
Why?
Megakaryocytes
7
2004
66
0.820
Why?
Hospital Mortality
2
2008
131
0.820
Why?
Randomized Controlled Trials as Topic
5
1998
400
0.810
Why?
Cardiopulmonary Bypass
1
2012
46
0.790
Why?
Immunoglobulin G
12
1983
491
0.780
Why?
Bacterial Infections
7
1982
127
0.780
Why?
Aged
28
1978
6986
0.770
Why?
Erythropoietin
2
1998
25
0.760
Why?
Hematopoietic Stem Cell Transplantation
4
2003
124
0.760
Why?
Hemostasis
2
2010
61
0.750
Why?
Postoperative Hemorrhage
1
2011
19
0.740
Why?
Meta-Analysis as Topic
2
1998
36
0.740
Why?
Leukocyte Transfusion
1
2010
5
0.700
Why?
Adult
34
1978
10906
0.680
Why?
Blood Group Antigens
7
1978
36
0.680
Why?
Interleukins
1
2010
63
0.680
Why?
Rh Isoimmunization
2
1987
14
0.670
Why?
Colorectal Neoplasms
4
1990
138
0.670
Why?
Peroxisome Proliferator-Activated Receptors
1
2009
3
0.660
Why?
Clofibric Acid
1
2009
5
0.660
Why?
Hypolipidemic Agents
1
2009
15
0.660
Why?
Th2 Cells
5
1996
89
0.660
Why?
Plateletpheresis
5
1981
9
0.660
Why?
Plasma
5
1982
33
0.640
Why?
Heart-Assist Devices
1
2009
33
0.630
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2009
43
0.620
Why?
Pregnancy
12
1978
1919
0.610
Why?
Graft Survival
3
1988
145
0.610
Why?
Transplantation, Homologous
10
1991
261
0.600
Why?
Incidence
7
1990
644
0.600
Why?
Health Plan Implementation
2
2002
17
0.600
Why?
Communicable Disease Control
1
2007
24
0.580
Why?
Heart Valve Prosthesis Implantation
2
2002
9
0.570
Why?
Platelet Activation
5
2006
51
0.570
Why?
Sepsis
4
1979
107
0.560
Why?
Antigen-Antibody Complex
3
1989
56
0.520
Why?
Blood Loss, Surgical
3
2004
44
0.510
Why?
Cohort Studies
9
1996
912
0.500
Why?
Th1 Cells
3
1996
72
0.500
Why?
Catheters, Indwelling
1
2005
69
0.490
Why?
Rh-Hr Blood-Group System
6
1978
47
0.470
Why?
Immunoglobulin M
4
1983
146
0.460
Why?
Treatment Outcome
9
1990
2487
0.450
Why?
Hip Prosthesis
2
1991
32
0.450
Why?
Interleukin-10
3
1998
99
0.430
Why?
Cytokines
4
1995
555
0.430
Why?
Bone Marrow
2
2003
282
0.430
Why?
Head and Neck Neoplasms
1
2004
78
0.430
Why?
Antineoplastic Agents
4
1974
598
0.420
Why?
PPAR gamma
4
2006
92
0.410
Why?
Cost-Benefit Analysis
6
1983
200
0.410
Why?
NF-kappa B
3
2009
405
0.410
Why?
Infant, Newborn
7
1983
1772
0.400
Why?
Child
9
1983
3897
0.390
Why?
Heart Diseases
1
2002
132
0.390
Why?
Risk Factors
12
1988
2172
0.390
Why?
Prospective Studies
6
1990
1606
0.390
Why?
Dinoprostone
2
2001
189
0.380
Why?
Infant
6
1980
2102
0.360
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2001
82
0.360
Why?
P Blood-Group System
2
1987
2
0.360
Why?
Interleukin-6
3
2007
314
0.340
Why?
Enzyme-Linked Immunosorbent Assay
10
1983
459
0.340
Why?
Time Factors
13
1974
3047
0.340
Why?
Antigens
2
1987
101
0.330
Why?
Immune System
2
1992
72
0.330
Why?
Prostaglandin D2
3
2004
61
0.330
Why?
Kidd Blood-Group System
2
1983
2
0.320
Why?
Thrombopoiesis
2
2008
15
0.320
Why?
Uterine Cervical Neoplasms
3
1986
125
0.320
Why?
Autoimmune Diseases
2
1988
84
0.320
Why?
Virus Diseases
3
1990
82
0.320
Why?
Adolescent
8
1983
4513
0.320
Why?
Costs and Cost Analysis
4
1995
84
0.320
Why?
Arthroplasty, Replacement, Knee
1
1998
20
0.310
Why?
Arthroplasty, Replacement, Hip
1
1998
34
0.310
Why?
Child, Preschool
4
2001
2452
0.300
Why?
Acquired Immunodeficiency Syndrome
4
1983
207
0.300
Why?
Colonic Neoplasms
3
1985
122
0.290
Why?
Platelet Aggregation
5
1983
63
0.290
Why?
Lymphoma
2
1994
151
0.280
Why?
Acute Disease
5
1982
570
0.280
Why?
Kidney Transplantation
3
1984
174
0.280
Why?
Urinary Tract Infections
3
1991
64
0.280
Why?
Women's Health
2
2006
58
0.270
Why?
Receptors, Complement
1
1996
17
0.260
Why?
Receptors, Fc
1
1996
70
0.260
Why?
Antibody Specificity
4
1983
104
0.250
Why?
Bone Marrow Purging
1
1995
4
0.250
Why?
Platelet Count
5
1981
46
0.240
Why?
Cell Separation
5
1981
224
0.240
Why?
Prostatic Neoplasms
3
1986
548
0.230
Why?
Fetal Blood
4
1985
91
0.230
Why?
C-Reactive Protein
2
2010
118
0.230
Why?
Host vs Graft Reaction
1
1993
2
0.230
Why?
Hematologic Diseases
1
1993
40
0.220
Why?
Models, Biological
4
1974
982
0.220
Why?
Granulocytes
4
1978
80
0.220
Why?
Pathology
1
1993
32
0.210
Why?
Aged, 80 and over
7
1987
2423
0.210
Why?
Antigens, Human Platelet
2
1994
8
0.210
Why?
Aspirin
2
2007
58
0.210
Why?
Platelet Aggregation Inhibitors
2
2006
57
0.210
Why?
Biological Markers
2
2010
532
0.200
Why?
Postoperative Care
1
2012
123
0.200
Why?
Pulmonary Embolism
1
2012
57
0.200
Why?
Spinal Fusion
1
1992
53
0.200
Why?
Leukemia, Myeloid
1
1992
115
0.190
Why?
Neoplasm Staging
2
1988
326
0.190
Why?
Blood Proteins
1
1992
94
0.190
Why?
Publication Bias
1
2011
8
0.190
Why?
Animals
12
1982
15647
0.190
Why?
Organizational Policy
1
2011
28
0.190
Why?
Venous Thrombosis
1
2012
75
0.190
Why?
Fetomaternal Transfusion
2
1987
8
0.190
Why?
Tanacetum parthenium
1
2011
3
0.190
Why?
Outcome and Process Assessment (Health Care)
1
2011
74
0.190
Why?
Survival Analysis
3
1994
575
0.190
Why?
Guideline Adherence
1
2011
72
0.180
Why?
Risk
2
2000
343
0.180
Why?
Sesquiterpenes
1
2011
19
0.180
Why?
Feasibility Studies
1
2011
189
0.180
Why?
Pulmonary Circulation
1
2010
47
0.180
Why?
Publishing
1
2011
45
0.180
Why?
Graft vs Host Disease
4
1994
92
0.180
Why?
Program Evaluation
1
2011
170
0.180
Why?
Ligands
3
2006
287
0.180
Why?
Uremia
1
1990
27
0.170
Why?
Rectal Neoplasms
2
1986
82
0.170
Why?
Fibrinolytic Agents
1
2010
59
0.170
Why?
Calcitonin
1
2010
41
0.170
Why?
Interleukin-12
1
2010
40
0.170
Why?
Drug Resistance
1
2010
97
0.170
Why?
Heart Defects, Congenital
1
2010
88
0.170
Why?
United States
6
1996
2511
0.170
Why?
Protein Precursors
1
2010
82
0.170
Why?
Neutralization Tests
2
1983
128
0.170
Why?
Hospitalization
1
2012
354
0.160
Why?
Prognosis
4
1988
1030
0.160
Why?
Odds Ratio
2
2007
301
0.160
Why?
Thromboxane B2
2
2004
11
0.160
Why?
Heparin
1
2010
116
0.160
Why?
Intensive Care Units
1
2010
106
0.160
Why?
Forkhead Transcription Factors
1
2009
51
0.160
Why?
Immunization
2
1983
153
0.160
Why?
Proteome
1
2009
50
0.160
Why?
Heart Transplantation
1
2009
62
0.160
Why?
Hematocrit
3
1981
109
0.160
Why?
Anticoagulants
1
2010
128
0.160
Why?
Heme Oxygenase-1
1
2008
46
0.160
Why?
Proteomics
1
2009
73
0.160
Why?
Antibodies, Monoclonal
3
1984
725
0.150
Why?
Erythrocyte Count
1
1988
25
0.150
Why?
Transport Vesicles
1
2008
7
0.150
Why?
Databases, Factual
1
2009
147
0.150
Why?
Retinoid X Receptors
1
2008
25
0.150
Why?
Immunity, Innate
1
1989
103
0.150
Why?
Culture Media, Conditioned
1
2007
60
0.150
Why?
Jurisprudence
1
1987
11
0.140
Why?
Confidentiality
1
1987
18
0.140
Why?
Research
1
2008
169
0.140
Why?
Surgical Wound Infection
1
2007
57
0.140
Why?
Erythroblastosis, Fetal
2
1983
35
0.140
Why?
Intraoperative Care
2
1988
29
0.140
Why?
Gene Expression Regulation, Enzymologic
1
2008
188
0.140
Why?
Patient Care
1
1987
34
0.140
Why?
Vaccines, Synthetic
1
1987
89
0.140
Why?
Leukopenia
1
2006
24
0.140
Why?
Immunosorbent Techniques
4
1983
27
0.140
Why?
Diabetes Mellitus, Type 2
1
2009
208
0.140
Why?
Plasma Exchange
2
1983
16
0.140
Why?
Graft Rejection
2
1984
142
0.140
Why?
Eicosanoids
1
2006
16
0.140
Why?
Proportional Hazards Models
1
2007
398
0.130
Why?
Antigens, CD40
1
2006
55
0.130
Why?
Lung Injury
1
2006
78
0.130
Why?
Hemagglutination Tests
4
1983
25
0.130
Why?
New York
2
2005
1191
0.130
Why?
Family Practice
1
1987
168
0.130
Why?
Recurrence
3
1989
656
0.120
Why?
Thalassemia
1
2005
21
0.120
Why?
Vidarabine
1
2005
27
0.120
Why?
Diabetes Mellitus
1
2006
162
0.120
Why?
Antineoplastic Combined Chemotherapy Protocols
2
1992
409
0.120
Why?
Anemia, Sickle Cell
1
2005
46
0.120
Why?
Cytomegalovirus Infections
1
2004
77
0.120
Why?
Erythrocyte Aging
2
1982
6
0.120
Why?
Hemagglutinins
1
1984
22
0.110
Why?
Neutrophils
1
2006
307
0.110
Why?
Infant, Premature
1
2005
230
0.110
Why?
Agglutinins
1
1983
4
0.110
Why?
Antigens, Thy-1
1
2003
59
0.110
Why?
Blood
3
1982
92
0.110
Why?
Disease-Free Survival
1
2004
191
0.110
Why?
Chloroquine
3
1984
19
0.110
Why?
Blood Coagulation Tests
1
1983
35
0.110
Why?
Age Factors
4
1982
1060
0.110
Why?
Technetium
1
1983
46
0.110
Why?
Tissue Donors
1
2003
69
0.110
Why?
Muscle, Smooth
1
2003
102
0.110
Why?
Iron
1
2004
138
0.110
Why?
Heart Valves
1
2002
6
0.110
Why?
Receptors, Cytoplasmic and Nuclear
1
2004
128
0.100
Why?
Sample Size
1
2002
32
0.100
Why?
Down-Regulation
2
1990
227
0.100
Why?
Cardiovascular Diseases
1
2006
250
0.100
Why?
Erythrocyte Membrane
1
1983
83
0.100
Why?
Hemodilution
1
2002
8
0.100
Why?
Sex Characteristics
1
2003
138
0.100
Why?
Immunoenzyme Techniques
1
1983
220
0.100
Why?
Health
1
1982
13
0.100
Why?
Probability
3
1983
289
0.100
Why?
Safety
1
2002
99
0.100
Why?
Antihypertensive Agents
1
1982
77
0.100
Why?
Leukemia, Myeloid, Acute
1
2003
172
0.100
Why?
Adjuvants, Immunologic
1
2002
118
0.100
Why?
Chromatography, Gel
2
1989
110
0.100
Why?
Aging
1
2007
692
0.100
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2001
14
0.100
Why?
Purpura
1
2001
17
0.100
Why?
Adrenal Cortex Hormones
1
1982
98
0.090
Why?
Heart Valve Prosthesis
1
2001
33
0.090
Why?
Survival Rate
1
2003
584
0.090
Why?
Plasmapheresis
1
1981
25
0.090
Why?
Antigen-Antibody Reactions
2
1989
40
0.090
Why?
Twins, Conjoined
1
1980
3
0.090
Why?
Duodenal Obstruction
1
1980
9
0.090
Why?
Cells, Cultured
4
2003
2367
0.090
Why?
Patient Advocacy
1
2000
48
0.090
Why?
Patient Selection
1
2002
197
0.090
Why?
Research Design
1
2002
326
0.090
Why?
Clinical Trials as Topic
2
1998
664
0.090
Why?
Hemoglobinopathies
3
1983
8
0.090
Why?
Cyclooxygenase 2
1
2001
211
0.090
Why?
Prostaglandin-Endoperoxide Synthases
1
2001
159
0.090
Why?
Multiple Organ Failure
1
1999
38
0.080
Why?
Mass Screening
1
1982
223
0.080
Why?
Cell Line
3
2004
1554
0.080
Why?
Health Status
1
1982
263
0.080
Why?
Fetus
1
1980
256
0.080
Why?
Hemoglobin A
1
1998
2
0.080
Why?
Serum Amyloid A Protein
1
1998
22
0.080
Why?
Receptors, Interleukin-2
1
1998
28
0.080
Why?
Decision Making
1
2000
220
0.080
Why?
Autoantibodies
2
1988
109
0.080
Why?
Isoenzymes
1
2001
391
0.080
Why?
Transcription Factors
1
2004
659
0.080
Why?
Lymphocyte Count
1
1998
52
0.080
Why?
Causality
1
1998
43
0.080
Why?
Quality-Adjusted Life Years
1
1998
50
0.080
Why?
History, 20th Century
1
1999
232
0.080
Why?
Emergencies
1
1978
78
0.080
Why?
Mice
5
1982
5900
0.080
Why?
Muramidase
1
1978
37
0.080
Why?
Interleukin-4
1
1998
160
0.070
Why?
Cell Adhesion
2
1988
253
0.070
Why?
Interleukin-2
1
1998
198
0.070
Why?
Logistic Models
2
2009
581
0.070
Why?
Immunocompromised Host
1
1998
84
0.070
Why?
Delivery of Health Care
1
1999
136
0.070
Why?
Data Collection
1
1998
201
0.070
Why?
Antilymphocyte Serum
2
1989
26
0.070
Why?
Flow Cytometry
3
1987
597
0.070
Why?
Prevalence
2
2006
530
0.070
Why?
Membrane Proteins
1
2001
530
0.070
Why?
Sex Distribution
2
2006
142
0.070
Why?
Quality of Life
1
2000
486
0.070
Why?
Thrombin
2
2007
132
0.070
Why?
Family
2
1987
198
0.070
Why?
Cell Line, Tumor
2
2008
543
0.070
Why?
Hospital Charges
1
1996
15
0.070
Why?
Binding, Competitive
3
1983
201
0.070
Why?
Reactive Oxygen Species
2
2008
295
0.070
Why?
RNA, Messenger
3
2004
1791
0.070
Why?
Recombinant Proteins
1
1998
706
0.070
Why?
Administration, Oral
2
1982
302
0.070
Why?
Thiazolidinediones
2
2004
62
0.060
Why?
Bone Marrow Cells
2
2004
220
0.060
Why?
Graft Enhancement, Immunologic
2
1990
3
0.060
Why?
Up-Regulation
2
2003
344
0.060
Why?
Sex Factors
2
1982
561
0.060
Why?
Combined Modality Therapy
2
1988
459
0.060
Why?
Linear Models
1
1996
228
0.060
Why?
Mice, Inbred C57BL
2
2009
1613
0.060
Why?
Remission Induction
1
1995
155
0.060
Why?
Confounding Factors (Epidemiology)
1
1994
59
0.060
Why?
RNA, Neoplasm
1
1974
64
0.060
Why?
Multivariate Analysis
1
1995
487
0.060
Why?
Anemia, Aplastic
2
1983
25
0.060
Why?
Binding Sites
1
1996
688
0.060
Why?
Analysis of Variance
1
1996
705
0.060
Why?
Molecular Weight
1
1993
348
0.050
Why?
Immunoblotting
1
1993
210
0.050
Why?
Gastrointestinal Hemorrhage
2
1983
84
0.050
Why?
Reoperation
1
1993
182
0.050
Why?
Cell Survival
1
1994
537
0.050
Why?
Phenotype
2
1987
727
0.050
Why?
Hematinics
1
2012
7
0.050
Why?
Kidney Failure, Chronic
2
1983
117
0.050
Why?
Complement C2
1
1992
6
0.050
Why?
Immobilization
1
2012
28
0.050
Why?
Complement C4
1
1992
18
0.050
Why?
Fibroblasts
2
2003
514
0.050
Why?
Skilled Nursing Facilities
1
2012
21
0.050
Why?
Ambulatory Care Facilities
1
2012
28
0.050
Why?
Cross-Over Studies
1
2012
117
0.050
Why?
Hydrops Fetalis
1
1991
15
0.050
Why?
Antibody Formation
1
1992
176
0.050
Why?
Home Care Services
1
2012
43
0.050
Why?
Albumins
1
1992
54
0.050
Why?
Office Visits
1
2012
67
0.050
Why?
Cell Differentiation
2
2003
1021
0.050
Why?
Ultraviolet Rays
1
1992
191
0.050
Why?
Megakaryocyte Progenitor Cells
1
2011
3
0.050
Why?
Kinetics
2
1983
1377
0.050
Why?
Administration, Rectal
1
2010
5
0.050
Why?
Suppositories
1
2010
5
0.050
Why?
Medicare
1
2012
126
0.050
Why?
Immunosuppression
1
1990
64
0.040
Why?
Platelet Function Tests
1
2010
14
0.040
Why?
Melanoma
1
1992
133
0.040
Why?
Comorbidity
1
2012
365
0.040
Why?
Bone Neoplasms
1
1992
180
0.040
Why?
Bleeding Time
1
1990
10
0.040
Why?
Crohn Disease
1
1990
88
0.040
Why?
Age Distribution
1
2010
201
0.040
Why?
Leukemia, Megakaryoblastic, Acute
1
2009
10
0.040
Why?
Cell Shape
1
2009
21
0.040
Why?
Nitriles
1
2009
39
0.040
Why?
Emergency Service, Hospital
1
2012
187
0.040
Why?
Sulfones
1
2009
26
0.040
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2011
89
0.040
Why?
Deamino Arginine Vasopressin
1
1990
23
0.040
Why?
NF-kappa B p50 Subunit
1
2009
33
0.040
Why?
Michigan
1
2009
17
0.040
Why?
Cyclic AMP-Dependent Protein Kinases
1
2010
118
0.040
Why?
Clostridium difficile
1
2009
13
0.040
Why?
Inflammation Mediators
1
2010
108
0.040
Why?
Enterocolitis, Pseudomembranous
1
2009
18
0.040
Why?
Pregnancy Complications
1
1991
194
0.040
Why?
Integrin alpha2beta1
1
2009
8
0.040
Why?
Immune Sera
1
1989
74
0.040
Why?
Adsorption
1
1989
88
0.040
Why?
Case-Control Studies
1
2011
587
0.040
Why?
Immunity, Cellular
1
1990
135
0.040
Why?
Transcription Factor RelA
1
2009
75
0.040
Why?
Hemophilia A
1
1989
29
0.040
Why?
Blood Cells
1
2009
18
0.040
Why?
Chromatography, Ion Exchange
1
1989
61
0.040
Why?
Dose-Response Relationship, Immunologic
1
1988
60
0.040
Why?
von Willebrand Diseases
1
1989
23
0.040
Why?
Mass Spectrometry
1
2009
115
0.040
Why?
Statistics as Topic
1
2009
177
0.040
Why?
Hospitals
1
2009
60
0.040
Why?
European Continental Ancestry Group
1
2010
225
0.040
Why?
Chromatography, High Pressure Liquid
1
2009
206
0.040
Why?
HIV Seropositivity
1
1988
32
0.040
Why?
Epidemiologic Research Design
1
2008
3
0.040
Why?
Species Specificity
1
2009
335
0.040
Why?
African Americans
1
2010
209
0.040
Why?
Multicenter Studies as Topic
1
1988
126
0.040
Why?
Acetylcysteine
1
2008
76
0.040
Why?
Retinoid X Receptor beta
1
2008
5
0.040
Why?
HLA-B Antigens
2
1984
12
0.040
Why?
Retinoid X Receptor alpha
1
2008
7
0.040
Why?
Thiazolidines
1
2008
11
0.040
Why?
Cause of Death
1
2009
155
0.040
Why?
Skin Diseases
1
2009
120
0.040
Why?
Bicyclo Compounds, Heterocyclic
1
2008
13
0.040
Why?
Radiation Injuries, Experimental
1
2008
82
0.040
Why?
Intraoperative Period
1
1987
45
0.040
Why?
Respiratory Tract Infections
1
2009
150
0.040
Why?
Anemia, Refractory
1
1987
7
0.040
Why?
Binding Sites, Antibody
2
1983
33
0.040
Why?
Parental Notification
1
1987
2
0.040
Why?
Pregnant Women
1
1987
4
0.040
Why?
Minors
1
1987
5
0.040
Why?
Protein Isoforms
1
2008
106
0.040
Why?
State Government
1
1987
13
0.040
Why?
Contraception
1
1987
22
0.040
Why?
Dimerization
1
2008
154
0.040
Why?
Confidence Intervals
1
2007
155
0.040
Why?
Liability, Legal
1
1987
23
0.040
Why?
Blotting, Western
1
2009
617
0.040
Why?
Regression Analysis
1
1988
489
0.040
Why?
Kidney Diseases
1
1989
167
0.040
Why?
Sexually Transmitted Diseases
1
1987
29
0.030
Why?
Disseminated Intravascular Coagulation
1
1986
14
0.030
Why?
Specimen Handling
1
2007
70
0.030
Why?
Child Abuse
1
1987
44
0.030
Why?
Glutathione
1
2008
222
0.030
Why?
Blood Coagulation Disorders
1
1986
36
0.030
Why?
Antioxidants
1
2008
200
0.030
Why?
Reference Values
1
2007
427
0.030
Why?
Collagen
1
2008
270
0.030
Why?
Risk Assessment
1
2010
808
0.030
Why?
Cross-Linking Reagents
1
2006
79
0.030
Why?
Monocytes
1
2008
294
0.030
Why?
Peptide Fragments
1
2008
277
0.030
Why?
Mice, Knockout
1
2009
857
0.030
Why?
Cell Proliferation
1
2009
480
0.030
Why?
Parents
1
1987
153
0.030
Why?
Physicians
1
1987
143
0.030
Why?
Drug Delivery Systems
1
2006
59
0.030
Why?
Pancytopenia
1
2005
13
0.030
Why?
Transplantation Chimera
1
2005
26
0.030
Why?
Leukocyte Count
2
1981
152
0.030
Why?
Algorithms
1
2009
518
0.030
Why?
Protein Binding
1
2008
812
0.030
Why?
Young Adult
1
2009
1013
0.030
Why?
Whole-Body Irradiation
1
2005
78
0.030
Why?
HLA-A2 Antigen
1
1984
8
0.030
Why?
Maternal-Fetal Exchange
1
1985
139
0.030
Why?
Cell Membrane
1
2006
474
0.030
Why?
MNSs Blood-Group System
1
1983
5
0.030
Why?
Follow-Up Studies
1
1988
1757
0.030
Why?
Myometrium
1
2003
21
0.030
Why?
Cryoglobulins
1
1983
25
0.030
Why?
Chromium Radioisotopes
1
1983
7
0.030
Why?
Sodium Pertechnetate Tc 99m
1
1983
9
0.030
Why?
Immunosuppressive Agents
1
2005
200
0.030
Why?
Hypoglycemic Agents
1
2004
100
0.030
Why?
Orbit
1
2003
64
0.030
Why?
Purpura, Thrombotic Thrombocytopenic
1
1983
10
0.030
Why?
Cost Control
1
1983
33
0.030
Why?
Hypotension, Orthostatic
1
1982
11
0.030
Why?
Lymphocytes
1
1984
293
0.030
Why?
DNA
1
2008
831
0.030
Why?
Endothelium, Vascular
1
2006
401
0.030
Why?
Actins
1
2003
184
0.030
Why?
Centrifugation
2
1978
45
0.030
Why?
Red Cross
1
1982
1
0.030
Why?
Connecticut
1
1982
7
0.030
Why?
Adenosine Triphosphate
1
2004
394
0.020
Why?
Glycerol
1
1982
53
0.020
Why?
Injections, Intravenous
1
1982
125
0.020
Why?
Interferon-gamma
1
2003
340
0.020
Why?
Evaluation Studies as Topic
2
1987
240
0.020
Why?
Prednisone
1
1982
178
0.020
Why?
Fluid Therapy
1
1981
30
0.020
Why?
Transforming Growth Factor beta
1
2003
362
0.020
Why?
Dexamethasone
1
1982
176
0.020
Why?
Gene Expression
1
2004
723
0.020
Why?
Heart Injuries
1
1960
14
0.020
Why?
Lung
1
2006
1132
0.020
Why?
DNA-Binding Proteins
1
2004
661
0.020
Why?
Military Medicine
1
1978
18
0.020
Why?
Dose-Response Relationship, Drug
1
1982
1085
0.020
Why?
Intestinal Obstruction
1
1958
36
0.020
Why?
Resuscitation
1
1978
47
0.020
Why?
Hospitals, Teaching
1
1978
79
0.020
Why?
Filtration
1
1978
29
0.020
Why?
L-Lactate Dehydrogenase
1
1978
81
0.020
Why?
Hemoglobins
1
1978
92
0.020
Why?
Transplantation Immunology
1
1996
17
0.020
Why?
Isoantigens
1
1996
23
0.020
Why?
Adoptive Transfer
1
1996
29
0.020
Why?
Lymphocyte Subsets
1
1996
28
0.020
Why?
Mice, Inbred Strains
1
1996
238
0.020
Why?
Forecasting
1
1996
172
0.020
Why?
Histocompatibility
1
1994
14
0.020
Why?
Neoplasm Metastasis
1
1996
219
0.020
Why?
Transplantation, Autologous
1
1994
136
0.010
Why?
Dactinomycin
1
1974
55
0.010
Why?
Poly I-C
1
1974
11
0.010
Why?
Ribonucleases
1
1974
70
0.010
Why?
Carmustine
1
1992
35
0.010
Why?
Dacarbazine
1
1992
17
0.010
Why?
Pregnancy Trimester, Third
1
1991
48
0.010
Why?
Antibodies, Anti-Idiotypic
1
1991
54
0.010
Why?
Karyotyping
1
1991
107
0.010
Why?
Prenatal Diagnosis
1
1991
53
0.010
Why?
Cisplatin
1
1992
93
0.010
Why?
Tamoxifen
1
1992
80
0.010
Why?
Lymphatic Metastasis
1
1992
137
0.010
Why?
Cesarean Section
1
1991
70
0.010
Why?
Disease Susceptibility
1
1990
77
0.010
Why?
Burns
1
1990
62
0.010
Why?
Dogs
1
1990
465
0.010
Why?
HLA-A Antigens
1
1987
7
0.010
Why?
Immunoassay
1
1987
38
0.010
Why?
Hydrogen-Ion Concentration
1
1987
561
0.010
Why?
Predictive Value of Tests
1
1987
579
0.010
Why?
Vincristine
1
1983
57
0.010
Why?
Splenectomy
1
1983
36
0.010
Why?
Steroids
1
1983
54
0.010
Why?
Ultrafiltration
1
1982
8
0.010
Why?
Freezing
1
1982
30
0.010
Why?
Rats
1
1990
4185
0.010
Why?
Drug Packaging
1
1982
8
0.010
Why?
Candidiasis
1
1982
36
0.010
Why?
Paresthesia
1
1981
18
0.010
Why?
Cellulitis
1
1979
11
0.010
Why?
Rectal Diseases
1
1979
18
0.010
Why?
Abscess
1
1979
48
0.000
Why?
Pneumonia
1
1979
188
0.000
Why?

Visualizations


Blumberg's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department